Koers Tetra Bio-Pharma Inc. Toronto S.E.
Aandelen
TBP
CA88166Y1007
Farmaceutische producten
Omzet 2020 | - | Omzet 2021 | - | Marktkapitalisatie | 88,81 mln. 121 mln. 81,48 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | -26 mln. -35,57 mln. -23,85 mln. | Nettowinst (verlies) 2021 | -52 mln. -71,14 mln. -47,71 mln. | EV/omzet 2020 | - |
Nettoliquiditeiten 2020 | 501K 685K 459K | Nettoliquiditeiten 2021 | 1,77 mln. 2,43 mln. 1,63 mln. | EV/omzet 2021 | - |
K/w-verhouding 2020 |
-1,86
x | K/w-verhouding 2021 |
-1,7
x | Werknemers | 33 |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 99,01% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 01-06-16 |
Natalie Leroux
IRC | Investor Relations Contact | - | - |
Michael Olders
PRN | Corporate Officer/Principal | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 01-06-16 |
Catherine Auld
BRD | Director/Board Member | - | 28-05-21 |
H. Norton
CHM | Chairman | 63 | 17-09-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+13,97% | 4,99 mld. | |
-32,08% | 3,61 mld. | |
-1,63% | 3,1 mld. | |
-24,62% | 2,64 mld. | |
-9,82% | 2,32 mld. | |
+38,87% | 1,85 mld. | |
+38,84% | 1,43 mld. | |
-15,47% | 1,39 mld. | |
+40,95% | 1,37 mld. |